Japan Y2K compliance on the rise:
This article was originally published in Clinica
Executive Summary
An increasing number of Japanese medical institutions are taking steps to protect themselves against the Y2K bug, according to a survey by the Japanese Medical Agency. Among the 15,000 medical institutions that took part in the survey, 91.7% were reported to have either completed, or are in the process of completing, their medical device inspections to ensure Y2K compliance, says Pharma Japan. The remaining 8.3% had either not started inspections or gave no response. An earlier study in June found that only 19% of medical institutions had completed their inspections, prompting concern over the country's slow response in tackling the millennium bug.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.